Technology | January 13, 2015

Ambry Genetics Launches Tiered Approach to Cardiovascular Genetic Testing

Testing panels for cardiomyopathies and arrhythmias offer enhanced analysis, faster turnaround time

Ambry Genetics, genetic testing, CardioNext, HCM, Rhythm

January 13, 2015 — Ambry Genetics announces the launch of cardiovascular genetic testing panels for inherited cardiomyopathies and arrhythmias. These feature an intuitive, tiered approach to testing for hypertrophic cardiomyopathy, long QT syndrome and Brugada syndrome. Sudden death may be the first and only symptom of some of these disorders. Genetic testing can be life-saving and directly impacts medical care when confirming a diagnosis and/or identifying at-risk individuals. These new panels feature next-generation sequencing, deletion/duplication analysis, comprehensive coverage and turnaround times as low as 3-4 weeks.

As with all of Ambry’s tests, cardiovascular genetic test reports will provide in-depth interpretation. An extensive literature review and assessment of all databases are performed when interpreting a gene mutation or variant of unknown significance (VUS).

The new testing includes an 84-gene comprehensive cardiovascular genetics panel (CardioNext), hypertrophic cardiomyopathy panels (HCMFirst and HCMNext), inherited arrhythmia panels (RhythmFirst and RhythmNext) and a comprehensive inherited cardiomyopathy panel (CMNext). Multi-gene panels targeted to specific inherited cardiomyopathies and arrhythmias are also available.

For more information: www.ambrygen.com

Related Content

Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Diagnostics | January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
ERT Acquires iCardiac Technologies
News | Cardiac Diagnostics | December 19, 2017
ERT recently announced it has acquired iCardiac Technologies, a provider of centralized cardiac safety and respiratory...
New Study Suggests Protein Could Protect Against Coronary Artery Disease

Patients with no obstructed blood flow in the coronary arteries had higher levels of CXCL5 (blue) compared to patients with moderate levels (green) or lower levels (yellow) of CXCL5, who had increased severity of coronary obstructions (indicated by the arrows). Credit: Schisler lab

News | Cardiac Diagnostics | December 07, 2017
December 7, 2017 — The buildup of plaque in the heart’s arteries is an unfortunate part of aging.
E-cigarettes Most Likely to be Used by Alcohol Drinkers and Former Cigarette Smokers, at American Heart Association (AHA), #AHA2017.
News | Cardiac Diagnostics | December 06, 2017
December 6, 2017 — Electronic cigarettes are more frequently used by people who recently quit smoking and alcohol dri
Lack of sleep may cause heart disease in older women. American heart Association, #AHA2017
News | Cardiac Diagnostics | December 06, 2017
December 6, 2017 — Older women who do not get enough sleep were more likely to have poor cardiovascular health, accor
New Tool Predicts Risk of Heart Attack in Older Surgery Patients
News | Cardiac Diagnostics | December 05, 2017
A tool designed to more accurately predict the risk of heart attack in older patients undergoing non-cardiac surgery...
EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

The EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

News | Cardiac Diagnostics | November 24, 2017
November 24, 2017 — Any physical activity in the elderly is better than none at all for reducing cardiovascular risk,
Analytics 4 Life Presents Clinical Data on Machine-Learned Cardiac Imaging Technology at TCT 2017
News | Cardiac Diagnostics | November 01, 2017
Analytics 4 Life announced it will be presenting new clinical data on the company's ongoing Coronary Artery Disease...
American Heart Association, Verily and AstraZeneca Launch One Brave Idea Science Innovation Center
News | Cardiac Diagnostics | October 20, 2017
The American Heart Association, Verily and AstraZeneca announced the opening of the One Brave Idea Science Innovation...
Overlay Init